HNF1B expression seems to play an important role in KRAS activation for pancreatic tumour, highlighting the need for additional studies to develop therapeutic strategies improving survival in PDAC (pancreatic ductal adenocarcinoma) patients. Here, HNF1B is linked to pancreatic neoplasm.